| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242451 | Respiratory Medicine | 2013 | 7 Pages |
Abstract
The present study demonstrates that ILPs improved significantly after using either device. Although significant correlations were found between the VAS and FIF50 and PIF for the nebulizer, in stable COPD patients, the pMDI plus spacer is a better route of administration than a nebulizer.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
S.K. Ramlal, F.J. Visser, W.C.J. Hop, P.N.R. Dekhuijzen, Y.F. Heijdra,